1. Home
  2. NSPR vs PSQH Comparison

NSPR vs PSQH Comparison

Compare NSPR & PSQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • PSQH
  • Stock Information
  • Founded
  • NSPR 2005
  • PSQH 2021
  • Country
  • NSPR United States
  • PSQH United States
  • Employees
  • NSPR N/A
  • PSQH N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • PSQH Advertising
  • Sector
  • NSPR Health Care
  • PSQH Consumer Discretionary
  • Exchange
  • NSPR Nasdaq
  • PSQH Nasdaq
  • Market Cap
  • NSPR 99.7M
  • PSQH 105.1M
  • IPO Year
  • NSPR N/A
  • PSQH N/A
  • Fundamental
  • Price
  • NSPR $2.35
  • PSQH $2.04
  • Analyst Decision
  • NSPR Strong Buy
  • PSQH Strong Buy
  • Analyst Count
  • NSPR 2
  • PSQH 2
  • Target Price
  • NSPR $4.50
  • PSQH $6.00
  • AVG Volume (30 Days)
  • NSPR 135.7K
  • PSQH 2.1M
  • Earning Date
  • NSPR 11-11-2025
  • PSQH 11-11-2025
  • Dividend Yield
  • NSPR N/A
  • PSQH N/A
  • EPS Growth
  • NSPR N/A
  • PSQH N/A
  • EPS
  • NSPR N/A
  • PSQH N/A
  • Revenue
  • NSPR $7,066,000.00
  • PSQH $27,580,806.00
  • Revenue This Year
  • NSPR $7.48
  • PSQH N/A
  • Revenue Next Year
  • NSPR $104.39
  • PSQH $38.69
  • P/E Ratio
  • NSPR N/A
  • PSQH N/A
  • Revenue Growth
  • NSPR 7.60
  • PSQH 93.83
  • 52 Week Low
  • NSPR $1.99
  • PSQH $1.55
  • 52 Week High
  • NSPR $3.80
  • PSQH $7.77
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 42.67
  • PSQH 48.66
  • Support Level
  • NSPR $2.30
  • PSQH $1.99
  • Resistance Level
  • NSPR $2.50
  • PSQH $2.50
  • Average True Range (ATR)
  • NSPR 0.09
  • PSQH 0.20
  • MACD
  • NSPR -0.01
  • PSQH -0.02
  • Stochastic Oscillator
  • NSPR 16.98
  • PSQH 31.58

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About PSQH PSQ Holdings Inc.

PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.

Share on Social Networks: